Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

5,800

Employees5,800

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

5,800

Employees5,800

MRNA Key Statistics

Market cap

9.61B

Market cap9.61B

Price-Earnings ratio

-2.85

Price-Earnings ratio-2.85

Dividend yield

—

Dividend yield—

Average volume

12.22M

Average volume12.22M

High today

$25.44

High today$25.44

Low today

$23.66

Low today$23.66

Open price

$23.87

Open price$23.87

Volume

14.87M

Volume14.87M

52 Week high

$170.47

52 Week high$170.47

52 Week low

$23.15

52 Week low$23.15

MRNA News

Simply Wall St 2d

Moderna (NasdaqGS:MRNA) Begins Phase 1 Study on Novel Cancer Therapy Candidate

initiated the dosing for its innovative mRNA-4106 cancer therapy in a Phase 1 trial, signaling ongoing advancements in their oncology pipeline. However, the com...

Analyst ratings

66%

of 29 ratings

Buy

20.7%

Hold

65.5%

Sell

13.8%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.